Beta

Proposal:Affordable Insulin Act of 2019

This proposal is archived and closed to further debate. It was introduced in the 116th Congress, which has concluded, and the bill was not enacted into law.
Geographic Scope
National

Description

Affordable Insulin Act of 2019

This bill addresses the importation of insulin from Canada and other foreign countries.

The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.

The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.

Bill Title

Affordable Insulin Act of 2019

Linked Goals

Steps

  • 2019-02-28: Referred to the House Committee on Energy and Commerce.
  • 2019-02-28: Introduced in House
  • 2019-02-28: Introduced in House
  • 2019-03-01: Referred to the Subcommittee on Health.

Projected Outcome

A more informed proposal or public response aligned with the Promote General Welfare goal.